© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 04, 2021
A higher percentage of patients suffering from a severe mental disorder such as schizophrenia or bipolar disorder, died from a COVID-19 infection than the control group.
January 18, 2021
Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.
January 16, 2021
Both monotherapy and combination of the unique regimen was shown to improve manic and depressive status at 12 weeks.
December 01, 2020
Repeated Transcranial Magnetic Stimulation shows more efficacy treating bipolar disorder than schizophrenia.
November 17, 2020
The agency did not find any efficacy or safety issues regarding the potential treatment for adults with schizophrenia or bipolar I disorder.
July 13, 2020
Patients with bipolar depression have struggled during the COVID-19 pandemic.
June 15, 2020
Association with familial history found in hospitalizations, suicide attempts, and an earlier onset of symptoms.
April 30, 2020
There were no significant differences observed in mood episodes for bipolar patients in either AISR therapy or standard treatment.
April 27, 2020
An analysis of 20-year outpatient prescribing trends show the drug class is being favored over mood stabilizers.
April 26, 2020
How do comorbidities influence patients' life expectancies? What is the role of public health programs?